Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase NA 1

Status

Completed 7Unknown 3Terminated 3Active not recruiting 2Withdrawn 1Recruiting 1Not yet recruiting 1

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Other neoplasm 3

Conditions

Breast Neoplasms 1127Neoplasms 982Carcinoma, Non-Small-Cell Lung 900Prostatic Neoplasms 594Neoplasm Metastasis 528Leukemia, Myeloid, Acute 513Colorectal Neoplasms 491Lung Neoplasms 487Melanoma 485Multiple Myeloma 477Pancreatic Neoplasms 385Lymphoma 369Ovarian Neoplasms 368Recurrence 365Lymphoma, Non-Hodgkin 346Leukemia 339Leukemia, Lymphocytic, Chronic, B-Cell 321Precursor Cell Lymphoblastic Leukemia-Lymphoma 291Head and Neck Neoplasms 276Carcinoma, Renal Cell 276Brain Neoplasms 273Carcinoma, Hepatocellular 261Glioblastoma 249Lymphoma, Large B-Cell, Diffuse 244Myelodysplastic Syndromes 242Squamous Cell Carcinoma of Head and Neck 241Lymphoma, Follicular 236Colonic Neoplasms 214Stomach Neoplasms 200Rectal Neoplasms 190

Interventions

penpulimab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Terminated × Advanced Malignant Neoplasm × Clear all
NCT06297642 2024-08-06

TQB2928 Injection Combined With Penpulimab in Treatment of Advanced Malignant Tumors.

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Phase 1 Terminated
3 enrolled
Other neoplasm

Advanced Malignant Neoplasm

NCT03049397 2021-11-17

Enhancing Connections Program in Improving Family Adjustment in Patients With Incurable Cancer

Fred Hutchinson Cancer Center

Phase NA Terminated
15 enrolled
Other neoplasm

Advanced Malignant Neoplasm

NCT03051035 2021-09-20

First-in-Human Study of KO-947 in Non-Hematological Malignancies

Kura Oncology, Inc.

Phase 1 Terminated
61 enrolled
Other neoplasm

Advanced Malignant Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon âš¡